Your Search Results

Bleeding and thrombotic risk in LAA closure patients

20 May 2026 – From EuroPCR 2026

This session provides a thorough examination of bleeding and thrombotic risks in patients undergoing left atrial appendage (LAA) closure. It reviews risk factors for device-related thrombosis, compares anticoagulation strategies post-procedure, and presents real-world clinical outcomes, particularly in high bleeding risk populations and special groups such as...

The digital pulse: innovation in the cathlab

20 May 2026 – From EuroPCR 2026

This session highlights transformative innovations in the catheterization laboratory that prioritize patient-centered care and enhanced safety. Focus areas include advancements in radiation practice through new technology and the integration of artificial intelligence to improve image analysis, decision-making, and procedural efficiency in interventional cardiology.

Complex transfemoral TAVI: how to manage the root to success

20 May 2026 – From EuroPCR 2026

Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.

INOCA/ANOCA: technical aspects

20 May 2026 – From EuroPCR 2026

This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...

Complications in CAD PCI

20 May 2026 – From EuroPCR 2026

This session focuses on the recognition and management of complications during coronary artery disease PCI. It includes cases of acute guide catheter crises, rare post-PCI chest pain etiologies, innovative stent retrieval techniques, and critical procedural challenges, providing an educational journey through complex complication management.

When transfemoral is not an option: is TAVI still possible?

20 May 2026 – From EuroPCR 2026

This session explores alternative access strategies for Transcatheter Aortic Valve Implantation (TAVI) when the transfemoral route is not feasible. It covers complex scenarios including transcaval TAVI complications, transaxillary approaches, management of extra-large annuli with peripheral artery disease, and innovative transcarotid valve-in-valve procedures.

Imaging and physiology-guided DCB strategy

20 May 2026 – From EuroPCR 2026

Delve into advanced imaging and physiology-guided drug-coated balloon (DCB) strategies for complex coronary lesions. This session presents integrated approaches combining morphology and physiology, OCT guidance, and real-world cases highlighting DCB use in multivessel disease and calcified lesions.

Other right-sided and tricuspid valve interventions

20 May 2026 – From EuroPCR 2026

This session focuses on right-sided heart valve interventions, particularly targeting tricuspid valve disease. Topics include clinical outcomes in atrial functional tricuspid regurgitation, management in the context of left-sided valvular disease, treatment approaches for tricuspid valve endocarditis, and advances in transcatheter therapies and device placements.

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.